India-based health care platform PharmEasy has raised USD220 million in an investment round led by Singaporean sovereign wealth fund Temasek Holdings. Additional investors in the round, which reportedly values the company at USD700 million, include Canadian pension fund Caisse de dépôt et placement du Québec (CDPQ); asset management group LGT; South Korea-based KB Financial Group; individual investors Nandan Nilekani and Sanjeev Aggarwal; and venture capital firms Bessemer Venture Partners, Orios Venture Partners, and Eight Roads Ventures. The company, which connects patients to local pharmacies and diagnostic centers through an online platform, will use the funding to improve the consumer experience, technology, and processes for timely and safe delivery of medicines.